Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.
Rohto Pharmaceutical Dividend Announcement
• Rohto Pharmaceutical announced a semi annually dividend of ¥17.00 per ordinary share which will be made payable on 2025-06-01. Ex dividend date: 2025-03-28
• Rohto Pharmaceutical's trailing twelve-month (TTM) dividend yield is 1.09%
Rohto Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2025-03-28 | ¥17.00 | semi annually | 2025-06-01 |
2024-09-27 | ¥16.00 | semi annually | 2024-12-05 |
2024-03-28 | ¥15.00 | semi annually | |
2023-09-28 | ¥12.00 | semi annually | 2023-12-07 |
2023-03-30 | ¥12.00 | semi annually | 2023-06-14 |
2022-09-29 | ¥5.00 | semi annually | 2022-12-01 |
2022-03-30 | ¥5.25 | semi annually | 2022-06-13 |
2021-09-29 | ¥3.75 | semi annually | 2021-12-02 |
2021-03-30 | ¥3.50 | semi annually | 2021-06-10 |
2020-09-29 | ¥3.25 | semi annually | 2020-12-03 |
2020-03-30 | ¥3.25 | semi annually | 2020-06-12 |
2019-09-27 | ¥3.25 | semi annually | 2019-12-05 |
2019-03-27 | ¥0.50 | semi annually | 2019-06-13 |
2018-09-26 | ¥2.75 | semi annually | 2018-12-07 |
2018-03-28 | ¥2.75 | semi annually | 2018-06-08 |
2017-09-27 | ¥2.75 | semi annually | 2017-12-07 |
2017-03-29 | ¥2.75 | semi annually | 2017-06-09 |
2016-09-28 | ¥2.50 | semi annually | |
2016-03-29 | ¥2.50 | semi annually | |
2015-09-28 | ¥2.50 | semi annually | |
2015-03-27 | ¥2.50 | semi annually | |
2014-09-26 | ¥2.25 | semi annually | |
2014-03-27 | ¥2.25 | semi annually |
Rohto Pharmaceutical Dividend per year
Rohto Pharmaceutical Dividend growth
Rohto Pharmaceutical Dividend Yield
Rohto Pharmaceutical current trailing twelve-month (TTM) dividend yield is 1.09%. Interested in purchasing Rohto Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Rohto Pharmaceutical Financial Ratios
Rohto Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Rohto Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Rohto Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Rohto Pharmaceutical's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Rohto Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Rohto Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Rohto Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Rohto Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Rohto Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Rohto Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Rohto Pharmaceutical's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Rohto Pharmaceutical's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.